Pfizer: 95 Percent Of Hormone Therapy Claims, 80 Percent Of Chantix Claims Settled

NEW YORK - Pfizer Inc. said Feb. 28 that it has settled or agreed to settle about 95 percent of its hormone replacement therapy (HRT) product liability cases and about 80 percent of its Chantix injury cases....(read more)